Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


Common drug can improve hand osteoarthritis symptoms: Study

Written by | 17 Oct 2023

Relief could be on the way for people with painful hand osteoarthritis after a Monash University and Alfred Health-led study found an affordable existing drug can help. Until… read more.

New research shows potential to reduce pain in women suffering from endometriosis

Written by | 6 Aug 2023

Pelvic pain in women with endometriosis is attributed to neuroinflammation. Researchers investigated biochemical mediators of endometriosis-associated pelvic pain to provide a foundation to identify new drugs to improve… read more.

Recent Advances in Anesthesiology

Written by | 16 Jan 2023

The pregnant women happenstance in the obstetric area have little or nothing to do with the patients of previous decades. Nowadays, women are older, with multiple pregnancies due… read more.

Comparing the cost-effectiveness of treatments for blood clots in cancer patients

Written by | 29 Dec 2022

Research conducted by UC Davis Comprehensive Cancer Center and the University of Cincinnati shows that direct oral anti-coagulant (DOAC) drugs are more effective and are more cost-effective than low molecular weight heparin (LMWH) for… read more.

EMA sets up expert group on medicine innovation

Written by | 27 Nov 2022

The European Medicines Agency (EMA) has established a Quality Innovation Expert Group (QIG) to support innovative approaches for the development, manufacture, and quality control of medicines for the… read more.

Nivolumab study supports use of immune checkpoint inhibitors in advanced skin cancer

Written by | 25 Oct 2022

Researchers report that patients with advanced cutaneous squamous cell carcinoma, a skin cancer and one of the most frequent malignancies worldwide, benefit from treatment with the immune checkpoint… read more.

Voice screening app delivers rapid results for Parkinson’s and severe COVID

Written by | 11 Oct 2022

A new screening test app could help advance the early detection of Parkinson’s disease and severe COVID-19, improving the management of these illnesses. Developed by a research team… read more.

Chlamydia’s stealthy cloaking device identified

Written by | 27 Sep 2022

Chlamydia, the leading cause of sexually transmitted bacterial infections, evades detection and elimination inside human cells by use of a cloaking device. But Duke University researchers have grasped… read more.

Simple skin biopsy can assess tissue damage related to COVID-19

Written by | 17 Jul 2022

Using skin biopsy samples, investigators found that patients with severe COVID-19 had clots in small venous and arterial blood vessels in skin that appears normal. This was not… read more.

Widely-used kidney function tests underestimate scale of kidney disease

Written by | 15 Jul 2022

The findings suggest that methods developed in high-income settings to check kidney function are not accurate for many people in Africa. Researchers from the African Research on Kidney… read more.

New study sheds light on why opioids can cause gastrointestinal problems

Written by | 10 Jul 2022

Opioids are the gold standard for treatment of chronic and acute pain; however, their use may result in significant gastrointestinal side effects, including nausea, vomiting, and constipation. The… read more.

Genetic screening algorithm could identify people with kidney disease risk

Written by | 21 Jun 2022

A new algorithm developed by researchers at Columbia University can analyze thousands of variants across the genome and estimate a person’s risk of developing chronic kidney disease —… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.